Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics

To estimate the cost and health benefits of implementing a risk factor-based prevention strategy for early-onset neonatal group B streptococcal (GBS) disease, using baseline assumptions and costs from a health maintenance organization. With the risk factor-based strategy, intrapartum antibiotics (IP...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 1999-04, Vol.103 (4), p.703-710
Hauptverfasser:	Mohle-Boetani, Janet C, Lieu, Tracy A, Ray, G. Thomas, Escobar, Gabriel, Neonatal GBS Prevention Working Group
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Bacterial diseases Biological and medical sciences Cohort Studies Cost-Benefit Analysis Decision Trees Diseases Female Fetal Membranes, Premature Rupture - drug therapy Fever - drug therapy Guideline Adherence - economics Health Care Costs - statistics & numerical data Health Maintenance Organizations - economics Human bacterial diseases Humans Infant, Newborn Infants (Newborn) Infectious diseases Length of Stay - economics Medical sciences Neonatal diseases Obstetric Labor Complications - drug therapy Obstetric Labor, Premature - drug therapy Practice Guidelines as Topic Pregnancy Prenatal Care - economics Prevention Risk Factors Staphylococcal infections, streptococcal infections, pneumococcal infections Streptococcal infections Streptococcal Infections - economics Streptococcal Infections - prevention & control Streptococcus agalactiae Value of Life
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!